← Back to Search

Enhanced Symptom Management for Cancer

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be a new patient at an outpatient palliative care clinic

Over 18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline - 16 weeks

Awards & highlights

Study Summary

This trial will compare the effects of two approaches to symptom management on quality of life for new patients referred to a palliative care oncology clinic.

Who is the study for?

This trial is for adults over 18 with cancer who are new patients at an outpatient palliative care clinic in Pennsylvania. It's not open to pregnant individuals or those who have previously used certain therapies focused on symptom management.Check my eligibility

What is being tested?

The study is testing the impact of additional resources for managing symptoms on the quality of life among cancer patients receiving palliative care, comparing two different approaches in a randomized controlled setting.See study design

What are the potential side effects?

Since this trial focuses on quality of life and symptom management rather than a specific medical treatment, it may not involve typical medication side effects. However, there could be emotional or psychological impacts from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a new patient at an outpatient palliative care clinic.

Select...

I am over 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline - 16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline - 16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline - 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Quality of Life - McGill Quality of Life Questionnaire

Secondary outcome measures

Acceptability of Accessing Additional Resources for Symptom Management

Feasibility of Accessing Additional Resources for Symptom Management

Hospital-Free Days

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Participants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic at which time they will be offered additional resources to promote symptom management. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use.

Group II: Usual CareActive Control1 Intervention

Participants in this group will consent to participate in a study about quality of life for patients with cancer seeking outpatient palliative care. They will be seen in a palliative care oncology clinic where they will receive symptom management and supportive care. They will be asked to complete a series of surveys every two weeks for 16 weeks which will assess their quality of life, symptoms, and medication use.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,002 Previous Clinical Trials

42,880,661 Total Patients Enrolled

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor

359 Previous Clinical Trials

104,726 Total Patients Enrolled

Abramson Cancer Center at Penn MedicineLead Sponsor

387 Previous Clinical Trials

145,326 Total Patients Enrolled

Media Library

Offering Additional Resources to Promote Symptom Management Clinical Trial Eligibility Overview. Trial Name: NCT05331625 — N/A

Cancer Research Study Groups: Intervention, Usual Care

Cancer Clinical Trial 2023: Offering Additional Resources to Promote Symptom Management Highlights & Side Effects. Trial Name: NCT05331625 — N/A

Offering Additional Resources to Promote Symptom Management 2023 Treatment Timeline for Medical Study. Trial Name: NCT05331625 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available in this experiment for participants to join?

"Affirmative. According to information on clinicaltrials.gov, this medical experiment is actively recruiting subjects. It was originally posted on November 3rd 2022 and received its last edit on the 8th of that same month. 208 potential participants are needed from a single site for successful completion of the trial."

Answered by AI

What is the upper limit on participant numbers for this research?

"Affirmative. Clinicaltrials.gov records demonstrate that this medical research, which commenced on November 3rd 2022, is still recruiting participants. 208 volunteers need to be drawn from 1 centre in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care

Scott Halpern 2022. "Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05331625.